<DOC>
	<DOCNO>NCT02244203</DOCNO>
	<brief_summary>Single Rising Dose ( SRD ) study : First evaluation safety , tolerability , pharmacokinetics pharmacodynamics BI 60732</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics BI 60732 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test Age ≥ 18 Age ≤ 45 year BMI ≥ 18.5 BMI ≤ 29.9 kg/m2 ( Body Mass Index ) Signed date write informed consent prior admission study accordance good clinical practice local legislation Any finding medical examination deviate normal clinical relevance . Repeated measurement systolic blood pressure great 140 mm Hg diastolic blood pressure great 90 mm Hg Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) Intake drug within one month le 10 halflives respective drug prior first study drug administration except relevant interaction rule Participation another trial investigational drug within 2 month prior first study drug administration Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( average consumption 30 g / day ) Drug abuse Blood donation ( 100 mL within four week prior start study ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen trial site A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) A history additional risk factor Torsade de pointes ( e.g. , heart failure , hypokalaemia , family history Long QT Syndrome ) Anaemia screen Subjects investigator 's judgement perceive increase risk bleeding , example : Hemorrhagic disorder bleed diathesis Occult blood faeces haematuria Trauma surgery within last month long excessive risk bleed persists event , plan surgery trial participation History arteriovenous malformation aneurysm History gastroduodenal ulcer disease gastrointestinal haemorrhage History intracranial , intraocular , spinal , retroperitoneal , atraumatic intraarticular bleeding Use drug may interfere haemostasis trial conduct ( e.g . acetylsalicylic acid nonsteroidal antiinflammatory drug ) Thrombocytopenia ( platelet count &lt; 100/nL )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>